Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...
CU Anschutz cardiologist John Carroll, MD, lends his expertise in mitral regurgitation and M-TEER procedures to veterinary researchers who hope to bring treatment options to man’s best friend ...
The MarketWatch News Department was not involved in the creation of this content. -- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimobendan) from ...
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results